Arca Biopharma reported $54.42M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 18520M 865M
Arca Biopharma ABIO:US $ 54.42M 14.31M
Biogen BIIB:US $ 7915.9M 59.4M
Brainstorm Cell Therapeutics BCLI:US $ 19.26M 4.02M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Capricor Therapeutics CAPR:US $ 59.63M 23.2M
Cytokinetics CYTK:US $ 623.53M 87.85M
Cytrx CYTR:US 6.18M 2.1M
Daiichi Sankyo 4568:JP Y 1345271M 34628M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Laboratory Of America LH:US $ 5229.5M 101M
Myriad Genetics MYGN:US $ 427.4M 57.4M
Otsuka Holdings 4578:JP Y 1065896M 16507M
Pfizer PFE:US $ 54420M 5273M
United Therapeutics UTHR:US $ 2586.6M 263M